Insys Therapeutics, Inc.

CIK 1516479 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Insys Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 11, 20208-K0001564590-20-004232
Feb 11, 202015-12B0001193125-20-031473
Feb 10, 20208-K0001564590-20-003962
Feb 5, 20208-K0001564590-20-003491
Jan 17, 20208-K0001564590-20-001346
Jan 10, 20208-K0001564590-20-000787
Jan 6, 20208-K0001564590-20-000232
Jan 3, 2020S-8 POS0001564590-20-000210
Jan 3, 2020S-8 POS0001564590-20-000206
Jan 3, 2020S-8 POS0001564590-20-000207
Jan 3, 2020S-8 POS0001564590-20-000213
Jan 3, 2020S-8 POS0001564590-20-000208
Dec 26, 20198-K0001564590-19-046971
Dec 3, 20198-K0001564590-19-045172
Nov 25, 2019NT 10-Q0001564590-19-044382
Nov 20, 20198-K0001564590-19-043982
Nov 19, 2019SC 13G0001213900-19-024010
Nov 4, 20198-K0001564590-19-039494
Oct 25, 20198-K0001564590-19-037825
Oct 2, 20198-K0001564590-19-036222
Sep 27, 20198-K0001564590-19-035729
Sep 26, 20198-K0001564590-19-035464
Sep 17, 20198-K0001564590-19-034903
Sep 9, 20198-K0001564590-19-034343
Sep 3, 20198-K0001564590-19-033822